Loading...
XLON
OXIG
Market cap2.13bUSD
Jul 10, Last price  
2,906.00GBP
Name

Oxford Instruments PLC

Chart & Performance

D1W1MN
XLON:OXIG chart
P/E
33.22
P/S
3.78
EPS
0.87
Div Yield, %
0.78%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
5.85%
Revenues
423m
-15.46%
161,600,000176,500,000206,500,000211,500,000262,300,000337,300,000350,800,000360,100,000380,100,000319,700,000300,200,000296,900,000314,000,000317,400,000318,500,000367,300,000444,700,000470,400,000500,600,000423,200,000
Net income
48m
+85.38%
-1,500,0002,700,000-6,700,00013,300,00032,200,00024,800,00022,000,00018,200,000-6,200,0007,000,000-25,500,00019,600,00030,000,00033,800,00041,800,00038,600,00058,600,00050,700,00026,000,00048,200,000
CFO
55m
+11.61%
5,200,000-100,00014,400,00031,100,00035,300,00041,600,00041,500,00021,200,00024,700,00039,300,00033,500,00030,500,00044,100,00055,200,00041,800,00049,200,00067,600,00042,400,00049,100,00054,800,000
Dividend
Nov 27, 20255.4 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1959 and headquartered in Abingdon, UK, Oxford Instruments plc operates as a global technology enterprise dedicated to the innovation, development, manufacturing, rental, sale, and maintenance of sophisticated scientific instruments and systems. Its global footprint extends across the United Kingdom, China, Japan, the United States, Germany, the broader European continent, and the rest of Asia, serving international markets. The company's operations are divided into three core business units: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The extensive product lineup includes advanced atomic force microscopy devices, along with vital tools for research and development that serve a wide array of sectors, including semiconductors, renewable energy, mining, metallurgy, and forensic science. It also supplies specialized etch and deposition processing equipment and solutions critical for applications in power and radio frequency devices, VCSELs/lasers, two-dimensional materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS/sensors, and quantum technologies. Furthermore, Oxford Instruments offers a comprehensive range of low-temperature systems, encompassing wet and magnet systems, advanced instrumentation, and bespoke custom solutions. The company's portfolio also features optical imaging products; Nuclear Magnetic Resonance (NMR) instruments, including spectrometers, quality control/assurance analyzers, and rock core analyzers, which are indispensable across diverse fields such as agriculture, food, automotive, aviation, construction, chemicals, environmental science, illicit drug testing, mining, pharmaceuticals, polymers, rock core analysis, textiles, and educational institutions. The enterprise also provides support products for MRI and CT imaging technologies, alongside scientific cameras, spectroscopy solutions, microscopy systems, and proprietary software. These are integral to applications in astronomy, bio-imaging and life sciences, energy generation and storage, forensics and environmental monitoring, photonics, quantum technology, semiconductors, microelectronics, and data storage. Moreover, Oxford Instruments manufactures X-ray tubes, power supplies, and integrated X-ray sources, catering to the analytical, medical imaging, food quality and packaging inspection, and industrial non-destructive testing (NDT) markets.
IPO date
Oct 12, 1983
Employees
2,000
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT